CD8⁺ Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4⁺ Tregs in mice

References

• Fu J, Heinrichs J, Yu XZ. Helper T-cell differentiation in graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation. Archivum Immunologiae Et Therapiae Experimentalis 2014; 62:277-301; PMID:24699629; http://dx.doi.org/10.1007/s00005-014-0284-z
   PubMed Web of Science ®Google Scholar
• Pasquini MC, Zhu X. Current uses and outcomes of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2015. Available at: http://www.cibmtr.org.
   Google Scholar
• Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15:430-5; PMID:12819471; http://dx.doi.org/10.1097/00002281-200307000-00010
   PubMed Web of Science ®Google Scholar
• Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005; 201:723-35; PMID:15753206; http://dx.doi.org/10.1084/jem.20041982
   PubMed Web of Science ®Google Scholar
• Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2:301-6; PMID:11276200; http://dx.doi.org/10.1038/86302
   PubMed Web of Science ®Google Scholar
• Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003; 198:1875-86; PMID:14676299; http://dx.doi.org/10.1084/jem.20030152
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61; PMID:12522256; http://dx.doi.org/10.1126/science.1079490
   PubMed Web of Science ®Google Scholar
• Trzonkowski P, Bieniaszewska M, Juscinska J, Dobyszuk A, Krzystyniak A, Marek N, Mysliwska J, Hellmann A. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin Immunol 2009; 133:22-6; PMID:19559653; http://dx.doi.org/10.1016/j.clim.2009.06.001
   PubMed Web of Science ®Google Scholar
• Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011; 117:1061-70; PMID:20952687; http://dx.doi.org/10.1182/blood-2010-07-293795
   PubMed Web of Science ®Google Scholar
• Di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, Bonifacio E, Del Papa B, Zei T, Ostini RI, Cecchini D et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011; 117:3921-8; PMID:21292771; http://dx.doi.org/10.1182/blood-2010-10-311894
   PubMed Web of Science ®Google Scholar
• Hippen KL, Merkel SC, Schirm DK, Nelson C, Tennis NC, Riley JL, June CH, Miller JS, Wagner JE, Blazar BR. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplantation 2011; 11:1148-57; PMID:21564534; http://dx.doi.org/10.1111/j.1600-6143.2011.03558.x
   PubMed Web of Science ®Google Scholar
• Semple K, Yu Y, Wang D, Anasetti C, Yu XZ. Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice. Biol Blood Marrow Transplantation 2011; 17:309-18; PMID:21224010; http://dx.doi.org/10.1016/j.bbmt.2010.12.710
   PubMed Web of Science ®Google Scholar
• Li J, Heinrichs J, Haarberg K, Semple K, Veerapathran A, Liu C, Anasetti C, Yu XZ. HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease. J Immunol 2015; 195:717-25; PMID:26048147; http://dx.doi.org/10.4049/jimmunol.1401250
   PubMed Web of Science ®Google Scholar
• Zheng J, Liu Y, Liu Y, Liu M, Xiang Z, Lam KT, Lewis DB, Lau YL, Tu W. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice. Sci Translational Med 2013; 5:168ra9; PMID:23325802; http://dx.doi.org/10.1186/1479-5876-11-168
   PubMed Web of Science ®Google Scholar
• Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, Kadidlo DM, McKenna DH, Bromberg JS, Levine BL, Riley JL et al. Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci Translational Med 2011; 3:83ra41; PMID:21593401; http://dx.doi.org/10.1126/scitranslmed.3001809
   PubMed Web of Science ®Google Scholar
• Sela U, Olds P, Park A, Schlesinger SJ, Steinman RM. Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. J Exp Med 2011; 208:2489-96; PMID:22084406; http://dx.doi.org/10.1084/jem.20110466
   PubMed Web of Science ®Google Scholar
• Beres AJ, Haribhai D, Chadwick AC, Gonyo PJ, Williams CB, Drobyski WR. CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity. J Immunol 2012; 189:464-74; PMID:22649199; http://dx.doi.org/10.4049/jimmunol.1200886
   PubMed Web of Science ®Google Scholar
• Koenecke C, Czeloth N, Bubke A, Schmitz S, Kissenpfennig A, Malissen B, Huehn J, Ganser A, Forster R, Prinz I. Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. Eur J Immunol 2009; 39:3091-6; PMID:19750478; http://dx.doi.org/10.1002/eji.200939432
   PubMed Web of Science ®Google Scholar
• Beres A, Komorowski R, Mihara M, Drobyski WR. Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease. Clin Cancer Res 2011; 17:3969-83; PMID:21558402; http://dx.doi.org/10.1158/1078-0432.CCR-10-3347
   PubMed Web of Science ®Google Scholar
• Zhang P, Tey SK, Koyama M, Kuns RD, Olver SD, Lineburg KE, Lor M, Teal BE, Raffelt NC, Raju J et al. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo. J Immunol 2013; 191:5291-303; PMID:24123683; http://dx.doi.org/10.4049/jimmunol.1301181
   PubMed Web of Science ®Google Scholar
• Robb RJ, Lineburg KE, Kuns RD, Wilson YA, Raffelt NC, Olver SD, Varelias A, Alexander KA, Teal BE, Sparwasser T et al. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation. Blood 2012; 119:5898-908; PMID:22538855; http://dx.doi.org/10.1182/blood-2011-12-396119
   PubMed Web of Science ®Google Scholar
• Fu W, Ergun A, Lu T, Hill JA, Haxhinasto S, Fassett MS, Gazit R, Adoro S, Glimcher L, Chan S et al. A multiply redundant genetic switch ‘locks in’ the transcriptional signature of regulatory T cells. Nat Immunol 2012; 13:972-80; PMID:22961053; http://dx.doi.org/10.1038/ni.2420
   PubMed Web of Science ®Google Scholar
• Zhao C, Shi G, Vistica BP, Hinshaw SJ, Wandu WS, Tan C, Zhang M, Gery I. Induced regulatory T-cells (iTregs) generated by activation with anti-CD3/CD28 antibodies differ from those generated by the physiological-like activation with antigen/APC. Cell Immunol 2014; 290:179-84; PMID:25038545; http://dx.doi.org/10.1016/j.cellimm.2014.06.004
   PubMed Web of Science ®Google Scholar
• Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 2009; 9:324-37; PMID:19390566; http://dx.doi.org/10.1038/nri2546
   PubMed Web of Science ®Google Scholar
• Luznik L, Fuchs EJ. Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation. Cancer Control 2002; 9:123-37; PMID:11965233
   PubMedGoogle Scholar
• Loren AW, Porter DL. Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation. Curr Opin Oncol 2006; 18:107-14; PMID:16462177; http://dx.doi.org/10.1097/01.cco.0000208781.61452.d3
   PubMed Web of Science ®Google Scholar
• Porter D, Levine JE. Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion. Seminars Hematol 2006; 43:53-61; http://dx.doi.org/10.1053/j.seminhematol.2005.09.005
   PubMed Web of Science ®Google Scholar
• Pasquini MC ZX. Current uses and outcomes of hematopoietic stem cell transplantation: 2014 CIBMTR Summary Slides. 2014
   Google Scholar
• Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL, Cohen JL. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003; 112:1688-96; PMID:14660744; http://dx.doi.org/10.1172/JCI17702
   PubMed Web of Science ®Google Scholar
• Haarberg KM, Li J, Heinrichs J, Wang D, Liu C, Bronk CC, Kaosaard K, Owyang AM, Holland S, Masuda E et al. Pharmacologic inhibition of PKCalpha and PKCtheta prevents GVHD while preserving GVL activity in mice. Blood 2013; 122:2500-11; PMID:23908466; http://dx.doi.org/10.1182/blood-2012-12-471938
   PubMed Web of Science ®Google Scholar
• Wu Y, Heinrichs J, Bastian D, Fu J, Nguyen H, Schutt S, Liu Y, Jin J, Liu C, Li QJ et al. MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice. Blood 2015; 126(11):1314-23; PMID:26138686; http://dx.doi.org/10.1182/blood-2015-02-0627356.
   PubMed Web of Science ®Google Scholar
• Liang Y, Liu C, Djeu JY, Zhong B, Peters T, Scharffetter-Kochanek K, Anasetti C, Yu XZ. Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects. Blood 2008; 111:954-62; PMID:17928532; http://dx.doi.org/10.1182/blood-2007-05-089573
   PubMed Web of Science ®Google Scholar
• Yu Y, Wang D, Liu C, Kaosaard K, Semple K, Anasetti C, Yu XZ. Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORgammat in mice. Blood 2011; 118:5011-20; PMID:21856864; http://dx.doi.org/10.1182/blood-2011-03-340315
   PubMed Web of Science ®Google Scholar